Inari Medical Stock Fundamentals
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
Inari Medical fundamentals help investors to digest information that contributes to Inari Medical's financial success or failures. It also enables traders to predict the movement of Inari Stock. The fundamental analysis module provides a way to measure Inari Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inari Medical stock.
Inari |
Inari Medical Company Return On Equity Analysis
Inari Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Inari Medical Return On Equity | -0.18 |
Most of Inari Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inari Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Inari Medical has a Return On Equity of -0.1772. This is 99.26% lower than that of the Health Care Equipment & Supplies sector and 97.97% lower than that of the Health Care industry. The return on equity for all United States stocks is 42.84% lower than that of the firm.
Inari Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inari Medical's current stock value. Our valuation model uses many indicators to compare Inari Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inari Medical competition to find correlations between indicators driving Inari Medical's intrinsic value. More Info.Inari Medical is regarded fifth in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inari Medical's earnings, one of the primary drivers of an investment's value.Inari Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inari Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics of similar companies.Inari Medical is currently under evaluation in return on equity category among its peers.
Inari Fundamentals
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0321 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 4.6 B | ||||
| Shares Outstanding | 58.56 M | ||||
| Shares Owned By Insiders | 8.99 % | ||||
| Shares Owned By Institutions | 95.50 % | ||||
| Number Of Shares Shorted | 2.48 M | ||||
| Price To Earning | 275.35 X | ||||
| Price To Book | 10.77 X | ||||
| Price To Sales | 8.15 X | ||||
| Revenue | 493.63 M | ||||
| Gross Profit | 498.76 M | ||||
| EBITDA | 15.19 M | ||||
| Net Income | (1.64 M) | ||||
| Cash And Equivalents | 330.5 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 32.05 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 10.04 X | ||||
| Book Value Per Share | 7.44 X | ||||
| Cash Flow From Operations | 35.93 M | ||||
| Short Ratio | 0.54 X | ||||
| Earnings Per Share | (1.35) X | ||||
| Price To Earnings To Growth | (1.88) X | ||||
| Target Price | 78.03 | ||||
| Number Of Employees | 1.3 K | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 4.68 B | ||||
| Total Asset | 674.24 M | ||||
| Retained Earnings | (48.49 M) | ||||
| Working Capital | 159.22 M | ||||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |